Infliximab trough level measured during treatment induction may be predictive of the loss of response to Infliximab during treatment maintenance in inflammatory bowel disease patients: a longitudinal observational retrospective study

被引：0
|
作者：
Liefferinckx, C. [1 ]
Minsart, C. [2 ]
Cremer, A. [1 ]
Amininejad, L. [1 ]
Toubeau, J. -F. [3 ]
Quertinmont, E. [2 ]
Deviere, J. [1 ]
Van Gossum, A. [1 ]
Franchimont, D. [1 ]
机构：
[1] Free Univ Brussels, Erasme Hosp, Gastroenterol, B-1050 Brussels, Belgium
[2] Univ Libre Bruxelles, Lab Expt Gastroenterol, Brussels, Belgium
[3] Univ Mons, Dept Elect Engn, B-7000 Mons, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P405
引用
收藏
页码：S303 / S304
页数：2
相关论文
共 50 条
  • [31] Therapeutic drug monitoring of infliximab for the management of loss of response in inflammatory bowel disease: an observational multicenter study
    Pugliese, D.
    Armuzzi, A.
    Tonucci, T. Panici
    Tolusso, B.
    Felice, C.
    Papa, A.
    Cantoro, L.
    Balestrieri, P.
    Civitelli, F.
    Bertani, L.
    Kohn, A.
    Cicala, M.
    Viola, F.
    Costa, F.
    Rapaccini, G. L.
    Guidi, L.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S300 - S300
  • [32] Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatment
    Krajcovicova, A.
    Batovsky, M.
    Gregus, M.
    Hlista, M.
    Durina, J.
    Leskova, Z.
    Sturdik, I
    Gojdic, M.
    Jalali, Y.
    Koller, T.
    Toth, J.
    Huorka, M.
    Hlavaty, T.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2018, 81 (04) : 465 - 470
  • [33] Infliximab biosimilar in the treatment of inflammatory bowel disease: a Japanese single-cohort observational study
    Hamanaka, S.
    Nakagawa, T.
    Koseki, H.
    Sakurai, T.
    Taida, T.
    Okimoto, K.
    Saito, K.
    Maruoka, D.
    Matsumura, T.
    Katsuno, T.
    Arai, M.
    Yokosuka, O.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S260 - S260
  • [34] Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease
    van Hoeve, Karen
    Dreesen, Erwin
    Hoffman, Ilse
    Van Assche, Gert
    Ferrante, Marc
    Gils, Ann
    Vermeire, Severine
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 68 (06): : 847 - 853
  • [35] Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease
    Gil Candel, Mayte
    Gascon Canovas, Juan Jose
    Urbieta Sanz, Elena
    Gomez Espin, Rosa
    Nicolas de Prado, Isabel
    Iniesta Navalon, Carles
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (05) : 360 - 366
  • [36] Distinct Association of Serum Vitamin D Concentration with Disease Activity and Trough Levels of Infliximab and Adalimumab during Inflammatory Bowel Disease Treatment
    Mechie, Nicolae-Catalin
    Mavropoulou, Eirini
    Ellenrieder, Volker
    Kunsch, Steffen
    Cameron, Silke
    Amanzada, Ahmad
    DIGESTION, 2020, 101 (06) : 761 - 770
  • [37] Infliximab trough levels among patients with inflammatory bowel disease in correlation with infliximab treatment escalation: a cross-sectional study from a Greek tertiary center
    Orfanidou, Afroditi
    Katsanos, Konstantinos
    Voulgaris, Theodoros
    Kofinas, Aristeidis
    Christodoulou, Maria Veatriki
    Konstandi, Maria
    Christodoulou, Dimitrios
    ANNALS OF GASTROENTEROLOGY, 2024, 37 (06):
  • [38] 1-Year Clinical Outcome of Subcutaneous Infliximab compared with Intravenous Infliximab in Patients with Inflammatory Bowel Disease During Maintenance Therapy
    Song, J. H.
    Hong, S. N.
    Kim, E. R.
    Kim, J. E.
    Chang, D. K.
    Kim, Y. H.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 661 - 662
  • [39] Vedolizumab trough levels during induction in IBD patients: A longitudinal observational retrospective study
    Liefferinckx, C.
    Cremer, A.
    Minsart, C.
    Gils, A.
    Amininejad, L.
    Tafciu, V.
    Quertinmont, E.
    Deviere, J.
    Van Gossum, A.
    Franchimont, D.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S491 - S492
  • [40] Usefulness of Co-Treatment With Immunomodulators in Inflammatory Bowel Disease Patients Treated With Infliximab Maintenance Therapy
    Sokol, Harry
    Seksik, Philippe
    Nion-Larmurier, Isabelle
    Vienne, Ariane
    Beaugerie, Laurent
    Cosnes, Jacques
    GASTROENTEROLOGY, 2010, 138 (05) : S528 - S528
12345